The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Effects of Graded Doses of Testosterone on Erythropoiesis in Healthy Young and Older Men
Open accessAbstract
CONTEXT: Erythrocytosis is a dose-limiting adverse effect of testosterone therapy, especially in older men. OBJECTIVE: Our objective was to compare the dose-related changes in hemoglobin and hematocrit in young and older men and determine whether age-related differences in erythropoietic response to testosterone can be explained by changes in erythropoietin and soluble transferrin receptor (sTfR) levels. DESIGN: We conducted a secondary analysis of data from a testosterone dose-response study in young and older men who received long-acting GnRH agonist monthly plus one of five weekly doses of testosterone enanthate (25, 50, 125, 300, or 600 mg im) for 20 wk. SETTING: The study took place at a General Clinical Research Center. PARTICIPANTS: Participants included 60 older men aged 60-75 yr and 61 young men aged 19-35 yr. OUTCOME MEASURES: Outcome measures included hematocrit and hemoglobin and serum erythropoietin and sTfR levels. RESULTS: Hemoglobin and hematocrit increased significantly in a linear, dose-dependent fashion in both young and older men in response to graded doses of testosterone (P<0.0001). The increases in hemoglobin and hematocrit were significantly greater in older than young men. There was no significant difference in percent change from baseline in erythropoietin or sTfR levels across groups in either young or older men. Changes in erythropoietin or sTfR levels were not significantly correlated with changes in total or free testosterone levels. CONCLUSIONS: Testosterone has a dose-dependent stimulatory effect on erythropoiesis in men that is more pronounced in older men. The testosterone-induced rise in hemoglobin and hematocrit and age-related differences in response to testosterone therapy may be mediated by factors other than erythropoietin and sTfR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Testosterone exerts erythrogenic effects that results in increases in both HCT and Hgb.23”
The cited source says what the claim attributes to it.
In the citing paper
“Circulating hemoglobin levels are androgen-dependent [82] and typically reported as 12% higher in males compared with females [4].”
From Transgender Women in the Female Category of Sport: Perspectives on Testosterone Suppression and Performance Advantage (2021) · cites this paper as [82]
In the citing paper
“In the Bhasin et al. (111) studies, in both young and older men the highest testosterone dose produced a 12% increase in blood hemoglobin compared with the lowest dose, reflecting a strong dose-response relationship (Fig. 6) (131).”
From Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance (2018) · cites this paper as [131]
In the citing paper
“Increased red blood cell mass (erythrocytosis) is the most common adverse event associated with testosterone therapy in clinical practice and in testosterone trials (2,3).”
From Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point (2014) · cites this paper as [3]
In the citing paper
“The meta-analyses of randomized testosterone trials have, however, reported very low frequency of neuro-occlusive events (2,3,20).”
From Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point (2014) · cites this paper as [3]
In the citing paper
“The effects of testosterone on red blood cell formation (hemoglobin and hematocrit) are dose dependent (14, 82, 83) while higher age is also a factor (44).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,094
Jones, M., Ibels, L. S., Schenkel, B., & Zagari, M. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 1,812
Kalantar‐Zadeh, K. (2017) · American Journal of Nephrology · doi:10.1159/000455387 · Cited by 1,149
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R., Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., & Ross, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3988 · Cited by 920
Calof, O. M., Singh, A. B., Lee, M. L., Kenny, A. M., Urban, R. J., Tenover, J. L., & Bhasin, S. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1451 · Cited by 728
Page, S. T., Amory, J. K., Bowman, F. D., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1933 · Cited by 566
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 404
Hormonal Changes During and After Cardiac Surgery
Maggio, M., Cattabiani, C., & Ceda, G. P. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0892-6_25 · Cited by 2
Hemochromatosis Unveiled by Testosterone Replacement in a Man with Hypogonadism
Gosmanov, A. R. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.02.049 · Cited by 2
Abdominale Beschwerden und Hypertonus bei einem 55‑jährigen Patienten
Kofler, T., Yueksel, F., Dirnhofer, S., Donath, M. Y., & Trendelenburg, M. (2016) · Der Internist · doi:10.1007/s00108-016-0170-3 · Cited by 2
Erythropoietin-Mediated Regulation of Central Respiratory Command
Seaborn, T., & Caravagna, C. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.02.006 · Cited by 2
Monitoring of Testosterone Replacement Therapy to Optimize the Benefit-to-Risk Ratio
Hayes, F. J. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.013 · Cited by 3
Choong, K. L. M., Jasuja, R., Basaria, S. S., Storer, T. W., & Bhasin, S. (2010) · Endocrine updates · doi:10.1007/978-1-4419-7014-5_9 · Cited by 2
Banyeh, M., Kangkpi, T., Bani, S. B., Zogli, K. E., Tanko, M. M., Atuahene, P. E., Iddrisu, A. Y., Ekor, C., Akoto, E. O., & Amidu, N. (2023) · Health Science Reports · doi:10.1002/hsr2.1547 · Cited by 2
Çelikhisar, H., & İlkhan, G. D. (2019) · Journal of Surgery and Medicine · doi:10.28982/josam.622377 · Cited by 2
Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency
Traish, A. M., & Morgentaler, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813197-8.00018-x · Cited by 2
Testosterone Use in the Perioperative Setting
Goyette, B. N., Hudnall, M. T., & Halpern, J. A. (2022) · Current Sexual Health Reports · doi:10.1007/s11930-021-00322-7 · Cited by 1
Hemoglobina y testosterona: importancia en la aclimatación y adaptación a la altura
Gonzales, G. F. (2011) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2011.281.462 · Cited by 1
Poopuangpairoj, T., Sirisopana, K., Ketsuwan, C., Kongchareonsombat, W., Phengsalae, Y., Matang, W., & Sangkum, P. (2024) · Research and Reports in Urology · doi:10.2147/rru.s476804 · Cited by 1
Male Hypogonadism: The Korean Society of Men's Health and Aging Position Statement
Ahn, S. T., Kim, Y., Yu, S. H., & Chung, Y. (2025) · The World Journal of Men s Health · doi:10.5534/wjmh.240266 · Cited by 1
Martinelli, C. V., Ercoli, A., Alfano, L., Pentimalli, F., Mazzarotti, G., Ferrantelli, G., LORENZO, A. D., Esposito, T., Giordano, A., & Cortellino, S. (2025) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2025.100620 · Cited by 1
Schoeberlein, M. I., Hudgins, J. H., DeVelasco, O., & Wilkins, B. W. (2025) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00913.2025 · Cited by 2
Kutscher, E. J., Silverman, E., & Bachi, K. (2026) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20250045 · Cited by 1
Abadom, M., Nyong, E., Hernandez, B. S., Saffati, G., Parikh, N. N., & Khera, M. (2026) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeag024 · Cited by 1
Tendon Injury Is Associated With Sex Hormone Therapy in the Active-Duty Population
Rebello, E. V., Edgeworth, D. B., Cummings, D. L., & White-Phillip, J. A. (2026) · Military Medicine · doi:10.1093/milmed/usag103 · Cited by 1
Testosterone-induced erythrocytosis affecting haematocrit prediction of fluid responsiveness
Alagarsamy, F., Khanna, G., Emerson, B., & Oakey, S. (2012) · British Journal of Hospital Medicine · doi:10.12968/hmed.2012.73.4.234a · Cited by 1
THE PREVALENCE OF ANAEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND LOW TESTOSTERONE
Dănoiu, S., Ă, D. M., Ionescu-Tîrgovi, C., & Davila, C. (2013) · Cited by 1
Bukovský, A. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i8.1109 · Cited by 1
Importance of Testosterone on Adaptation at High Altitude
Gonzales, G. F. (2018) · International Journal of Medical and Surgical Sciences · doi:10.32457/ijmss.2015.043 · Cited by 1
du Plessis, J. M., Bester, H. L., Julyan, M., & Cockeran, M. (2018) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2018.1553344 · Cited by 1
Shimabukuro, T., Ohmi, C., Nagamitsu, R., Shiraishi, K., & Matsuyama, H. (2021) · The Japanese Journal of Urology · doi:10.5980/jpnjurol.112.81 · Cited by 1
Initiating male contraception methods
Wu, F. C. W., & Lo, K. C. (2024) · Andrology · doi:10.1111/andr.13694 · Cited by 1
Neighbourhood socioeconomic disparities in immunohaematologic risk in a paediatric analytic cohort
Berg, K. A., Lad, S. U., Rose, H., Fiegl, J., Blazel, M., Einstadter, D., & Perzynski, A. T. (2025) · Longitudinal and Life Course Studies · doi:10.1332/17579597y2025d000000045 · Cited by 1
Treatment of Hypogonadism in Men
Mehta, A., Paduch, D. A., & Goldstein, M. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4405-2_5 · Cited by 1
S.R., س. ر. A. H., A., ا. R. L., & M., م. D. (2016) · Quarterly of Horizon of Medical Sciences · doi:10.18869/acadpub.hms.22.1.21 · Cited by 1
Male Sexual and Reproductive Health
Tharakan, T., Minhas, S., & Jayasena, C. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00036-0 · Cited by 1
Stevenson, M. O., & Tangpricha, V. (2022) · Springer eBooks · doi:10.1007/978-3-030-84367-0_56 · Cited by 1
Do androgens lead to increased erythropoiesis in women with congenital adrenal hyperplasia?
Karunasena, N., Elman, M., Mallappa, A., Merke, D. P., Ross, R. J. M., & Daniel, E. (2015) · Endocrine Abstracts · doi:10.1530/endoabs.38.p401 · Cited by 1
Grant, A. S. (2013) · UA Campus Repository (The University of Arizona)
Mechanisms of Hematopoiesis Control
Дыгай, А. М., & Жданов, В. В. (2014) · Springer eBooks · doi:10.1007/978-3-319-08584-5_1
Humana, C. D. M., & Humana, B. D. M. (2008)
Testosterone replacement therapy
Vrolyk, M. (2015) · OpenBU (Boston University)
Montori, V. M., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., & Ronald, S. H. (2010)
Undecanoate in Routine Clinical Practice
Middleton, T. L., Turner, L., Fennell, C., Savkovic, S., Jayadev, V., Conway, A., & Handelsman, D. J. (2015)
From the Editor Technology, Policy, and Personal Decision Making 91
Braverman, J., Chervenak, F. A., McCullough, L. B., & Santos, X. M. (2012)
Rattus norvegicusBerkenhout, 1769) Galur Wistar Jantan dan BetinaUmur 4, 6, dan 8 Minggu
Fitria, L., & Sarto, M. (2014)
Benefits and Adverses Effects of Testosterone Therapy
Costa, E. M. F., Amato, L. G. L., & Silveira, L. F. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_13
Saleem, M. M. N. M. (2017) · Journal of Al-Nahrain University-Science · doi:10.22401/jnus.20.2.05
Evaluation of Serum Testosterone Level in Men with Type 2 Diabetes Mellitus
Sangamesh, S. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i11.192
Carter, J., Goldfarb, S. B., Sonoda, Y., Nelson, C. J., Dickler, M. N., & Mulhall, J. P. (2017) · Wiley eBooks · doi:10.1002/9781119468868.ch28
Congenital and Acquired Polycythemias: Testosterone Induced Polycythemias
Nieschlag, E. (2008) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2008.0480c
Evaluation of hematological parameters in cases with premature adrenarche
Çelik, N., Çamtosun, E., & Dündar, İ. (2018) · Ortadoğu Tıp Dergisi · doi:10.21601/ortadogutipdergisi.429250
Oguejiofor, C. F., Ochiogu, I. S., Ogbu, V., & Okoro, O. (2018) · Open Journal of Veterinary Medicine · doi:10.4236/ojvm.2018.811017
Frailty and anabolic hormones in ageing men
O’Connell, M. D. L. (2011) · Research Explorer (The University of Manchester)
Treatment of Adult Male Hormonal Disorders
Clavijo, R. I. (2020) · Springer eBooks · doi:10.1007/978-3-030-28599-9_22
Testosterone Therapy in Male Infertility
Ramasamy, R., & Masterson, J. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-32300-4_72
Feitosa, G. S., de Freitas, L. A. R., Silva, J. P., & Reis, M. (2020) · Revista Científica Hospital Santa Izabel · doi:10.35753/rchsi.v2i4.113
Polycythemia: a mystery solved by history
Kalal, C. R., Patel, A., Wagh, A., Joshi, H., Jain, S. S., Surude, R. G., Bhatia, S. J., & Bhatt, C. B. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20204266
Evaluation of Anemia among Men and Women with Acute Renal Disease in Jos, Plateau State, Nigeria
Onuoha, E. C., Ike, E. M., Eledo, B. O., Hallie, F. E., Diepreye, T. A., Adaka, O. A., Osuji, L. A., Edeh, F. K., & Nelson-Ebi, N. (2020) · American Journal of Biochemistry and Molecular Biology · doi:10.3923/ajbmb.2020.51.55
Klinefelter Syndrome in adults: variability in clinical findings
Barbosa, M., Matta-Coelho, C., Fernandes, V., & Souto, S. B. (2021) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ao200036
Min, L., & Hopkins, R. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-18533-6_3
Saad, F. (2022) · Springer eBooks · doi:10.1007/978-3-662-61417-4_9
Benefits of Testosterone Treatment
Basaria, S. S., & Gagliano‐Jucá, T. (2022) · doi:10.1093/med/9780198870197.003.0489
Risks of Testosterone Treatment
Dobs, A. S., & Yalamanchi, S. (2022) · doi:10.1093/med/9780198870197.003.0490
(2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32832c937e
Hormone Replacement Therapy in Men
Pham, C. H., Wang, C., & Swerdloff, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99449-2
Peripheral Hematological Parameters in Sudanese Women with Polycystic Ovary Syndrome
Mohammed, S. A., Elhaj, E. T., Ahmed, M. A., Eltayeb, R., & Adam, I. (2022) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2022.117037
Testosterone Therapy in Oncologic Patients
Solsrud, E., Louters, M. M., & Pearlman, A. M. (2023) · Current Sexual Health Reports · doi:10.1007/s11930-022-00351-w
Reference values of Complete blood count in healthy adult EritreanPreprint
Noury, A. O., Musa, O. A. A., Gasmalbari, E., Bakhit, B. M., Tesfamariam, E. H., Abraha, D. M., Ghebre, Z. B., Suleman, O., Tesfay, E. G., & Hailezghi, F. G. (2023) · medRxiv · doi:10.1101/2023.03.02.23286685
Benefits and Adverse Events of Testosterone Therapy
Costa, E. M. F., Amato, L. G. L., & Silveira, L. F. G. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_16
Male Hypogonadism and Aging: An Update
Iglesias, P., Núñez, A., & Díez, J. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_9
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.003.0003
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.003.0005
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.003.0002
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.002.0005
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.003.0008
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.003.0007
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.003.0006
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.002.0003
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.003.0004
Ironing Out Evolutionary and Social Theory
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.003.0001
Re: Cardiovascular Safety of Testosterone-Replacement Therapy
Nackeeran, S., & Ramasamy, R. (2023) · European Urology · doi:10.1016/j.eururo.2023.09.014
Kavoussi, P. K., & Machen, G. L. (2023) · Cambridge University Press eBooks · doi:10.1017/9781009197533.033
Research progress of insulin-like peptide 3 in bone metabolismPreprint
Zhou, M., Liu, Y., Ji, C., Liang, J., Zhang, B., Wang, L., & Yang, X. (2024) · doi:10.22541/au.172201688.89826604/v1
Anabolic steroids and cardiovascular morbidity
Windfeld‐Mathiasen, J., Horwitz, H., Biering‐Sørensen, T., & Olsen, F. J. (2024) · Ugeskrift for Læger · doi:10.61409/v04240260
Vor- und Nachteile der Testosterontherapie
Costa, E. M. F., Amato, L. G. L., & Silveira, L. F. G. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_16
Männlicher Hypogonadismus und Alterung: ein Update
Iglesias, P., Núñez, A., & Díez, J. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_9
Helmi, E. D., Ahmed, S. I., Gad, M. S., Saad, M. A., Elneily, D., Attia, A. E., & Khedr, W. E. (2024) · Journal of acute care and resuscitation. · doi:10.4103/jacresus.jacresus_17_24
Reproductive and nonreproductive actions of testosterone
Gagliano‐Jucá, T., Jain, A., Jasuja, R., & Bhasin, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00198-9
Hormone replacement therapy, male
Wang, C., & Swerdloff, R. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00263-6
Practical Perspectives in Testosterone Therapy
Salter, C. A., Mulhall, J. P., & Schlegel, P. N. (2025) · Springer eBooks · doi:10.1007/978-3-031-55405-6_50
Testosterone and Cardiovascular Disease
Goldman, A., & Bhasin, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_30
Prevalence of metabolic and hematologic manifestations among women with polycystic ovarian syndrome
Dave R. Abenoja, C. L. A. (2025) · International Journal of Biomolecules and Biomedicine | IJBB · doi:10.12692/ijbb/20.3.13-31
Escalante, G., Mart, D. S., & Câmara, L. C. (2025) · Strength and conditioning journal · doi:10.1519/ssc.0000000000000931
Systemic Effects of Anabolic-Androgenic Steroid Abuse: A Case in Primary Care
Vilarinho, M. D. C., Cernadas, J., & Ferreira, M. M. (2025) · Cureus · doi:10.7759/cureus.93589
Engin, İ. (2025) · Hippocrates Medical Journal · doi:10.58961/hmj.1748826
Impact of Dapsone (MDT/WHO) on hematological tests of leprosy patients: A retrospective cohort studyPreprint
da Silva, C. M., Albertino, G. S., Wiezel, J. A., Cinto, F. A. C., Perecin, F. A. M. D. C., Lugão, H. B., Lima, F. R., & Frade, M. A. C. (2025) · medRxiv · doi:10.1101/2025.11.26.25341059
Anemia in acromegaly: Prevalence, etiologies, and predictors from a large tertiary center cohort
Fırlatan, B., Tekin, S., Şendur, S. N., Oğuz, S. H., Dağdelen, S., & Erbas, T. A. (2025) · Pituitary · doi:10.1007/s11102-025-01604-2
Testosterone Deficiency Syndrome
Meryn, S. (2014) · Springer eBooks · doi:10.1007/978-3-662-45018-5_10
Cardiovascular Safety of Testosterone Replacement Therapy in Hypogonadal Men
Kissock, J. (2024) · Canadian Diabetes & Endocrinology Today · doi:10.58931/cdet.2024.2330
Braga, M., Travison, T. G., Taplin, M., Habtemariam, D. A., Dufour, A. B., McDonnell, M. E., Simonson, D. C., Lin, A. P., Borwick, E., Chammas, L., et al. (2026) · Andrology · doi:10.1111/andr.70194
Čeponis, J., Wang, C., Swerdloff, R., & Liu, P. Y. (2026) · Endocrinology · doi:10.1007/978-3-319-29456-8_11-2
Identification de gènes candidats pour l'anémie de Blackfan-Diamond et caractérisation phénotypique
Saby, M. (2019) · theses.fr (ABES) · doi:10.70675/6af1f1f8za19cz47d2zb676zc0fece80504b
Shi, R., John, K., Qin, X., Haque, E., Liang, T., Cheryala, N., Li, F., Wong, H. L., & Georg, G. I. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00011
Endocrine Support for the Aesthetic Patient
Parsa, A. A., & Parsa, F. D. (2026) · Springer eBooks · doi:10.1007/978-3-032-03840-1_46
Choi, D., Hong, J. H., Lee, G., Kim, J., & Choi, C. (2026) · Medicina · doi:10.3390/medicina62071334
Metadata
- Authors
- Coviello, A. D., Kaplan, B., Lakshman, K. M., Chen, T., Singh, A. B., & Bhasin, S.
- Affiliations
- Boston University (US)
- Charles R. Drew University of Medicine and Science (US)
- Corresponding author
- Coviello, Andrea D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-03-01
- Volume
- 93
- Issue
- 3
- Pages
- 914-919
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2266950
- OpenAlex
- W2102205904
- Cited by
- 404
- References
- 38
- Citations by year
- 2026: 12 · 2025: 27 · 2024: 25 · 2023: 34 · 2022: 34 · 2021: 21 · 2020: 30 · 2019: 18 · 2018: 18 · 2017: 24 · 2016: 20 · 2015: 23 · 2014: 19 · 2013: 23 · 2012: 24
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- School of Medicine, Boston University
- National Institutes of Health
- National Institute on Aging (1R01 AG-14369-01, R01AG014369)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK049296, 2R01 DK49296-08, R01DK070534, R01DK059627)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD0434)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- testosterone replacement therapy, erythropoiesis, erythrocytosis, testosterone enanthate, dose-response relationship, hemoglobin, hematocrit, erythropoietin, soluble transferrin receptor, age differences, older men, GnRH agonist
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Dose-Response Relationship, Drug, Erythropoiesis, Erythropoietin, Hematocrit, Hemoglobins, Humans, Male, Middle Aged, Receptors, Transferrin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
